Systems Biology Based Drug Repositioning for Development of Cancer Therapy
| dc.contributor.author | Turanli, Beste | |
| dc.contributor.author | Altay, Ozlem | |
| dc.contributor.author | Boren, Jan | |
| dc.contributor.author | Turkez, Hasan | |
| dc.contributor.author | Nielsen, Jens | |
| dc.contributor.author | Uhlen, Mathias | |
| dc.contributor.author | Mardinoglu, Adil | |
| dc.date.accessioned | 2026-03-26T14:40:15Z | |
| dc.date.available | 2026-03-26T14:40:15Z | |
| dc.date.issued | 2021 | |
| dc.description | Turanli, Beste/0000-0003-1330-9712; Uhlen, Mathias/0000-0002-4858-8056 | en_US |
| dc.description.abstract | Drug repositioning is a powerful method that can assists the conventional drug discovery process by using existing drugs for treatment of a disease rather than its original indication. The first examples of repurposed drugs were discovered serendipitously, however data accumulated by high-throughput screenings and advancements in computational biology methods have paved the way for rational drug repositioning methods. As chemotherapeutic agents have notorious side effects that significantly reduce quality of life, drug repositioning promises repurposed noncancer drugs with little or tolerable adverse effects for cancer patients. Here, we review current drug-related data types and databases including some examples of web-based drug repositioning tools. Next, we describe systems biology approaches to be used in drug repositioning for effective cancer therapy. Finally, we highlight examples of mostly repurposed drugs for cancer treatment and provide an overview of future expectations in the field for development of effective treatment strategies. | en_US |
| dc.description.sponsorship | Knut and Alice Wallenberg Foundation | en_US |
| dc.description.sponsorship | We would like to thank Stephen Doran and Simon Lam of King's College London for editorial comments. This work was supported by Knut and Alice Wallenberg Foundation. | en_US |
| dc.identifier.doi | 10.1016/j.semcancer.2019.09.020 | |
| dc.identifier.issn | 1044-579X | |
| dc.identifier.issn | 1096-3650 | |
| dc.identifier.scopus | 2-s2.0-85072801840 | |
| dc.identifier.uri | https://doi.org/10.1016/j.semcancer.2019.09.020 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14901/1595 | |
| dc.language.iso | en | en_US |
| dc.publisher | Academic Press Ltd- Elsevier Science Ltd | en_US |
| dc.relation.ispartof | Seminars in Cancer Biology | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Systems Biology | en_US |
| dc.subject | Cancer | en_US |
| dc.subject | Drug Repositioning | en_US |
| dc.subject | Signature-Based Approaches | en_US |
| dc.subject | Network-Based Approaches | en_US |
| dc.title | Systems Biology Based Drug Repositioning for Development of Cancer Therapy | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Turanli, Beste/0000-0003-1330-9712 | |
| gdc.author.id | Uhlen, Mathias/0000-0002-4858-8056 | |
| gdc.author.scopusid | 57196402528 | |
| gdc.author.scopusid | 57211145548 | |
| gdc.author.scopusid | 57203198460 | |
| gdc.author.scopusid | 9134233800 | |
| gdc.author.scopusid | 55572933700 | |
| gdc.author.scopusid | 7102229224 | |
| gdc.author.scopusid | 6506016742 | |
| gdc.author.wosid | Mardinoglu, Adil/Aas-6360-2021 | |
| gdc.author.wosid | Türkez, Hasan/Aaq-4905-2020 | |
| gdc.author.wosid | Arga, Kazım Yalçın/Hgb-8786-2022 | |
| gdc.author.wosid | Nielsen, Jens/Q-1347-2017 | |
| gdc.author.wosid | Turanli, Beste/Aaa-7795-2021 | |
| gdc.author.wosid | Uhlen, Mathias/Aav-8746-2021 | |
| gdc.description.department | Erzurum Technical University | en_US |
| gdc.description.departmenttemp | [Turanli, Beste; Altay, Ozlem; Uhlen, Mathias; Mardinoglu, Adil] KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden; [Turanli, Beste; Arga, Kazim Yalcin] Marmara Univ, Dept Bioengn, Istanbul, Turkey; [Turanli, Beste] Istanbul Medeniyet Univ, Dept Bioengn, Istanbul, Turkey; [Boren, Jan] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden; [Boren, Jan] Sahlgrenska Univ Hosp Gothenburg, Gothenburg, Sweden; [Turkez, Hasan] Erzurum Tech Univ, Dept Mol Biol & Genet, TR-25240 Erzurum, Turkey; [Nielsen, Jens] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Mardinoglu, Adil] Kings Coll London, Ctr Host Microbiome Interact, Fac Dent Oral & Craniofacial Sci, London SE1 9RT, England | en_US |
| gdc.description.endpage | 58 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | 47 | en_US |
| gdc.description.volume | 68 | en_US |
| gdc.description.woscitationindex | Science Citation Index Expanded | |
| gdc.description.wosquality | Q1 | |
| gdc.identifier.pmid | 31568815 | |
| gdc.identifier.wos | WOS:000616365300006 | |
| gdc.index.type | Scopus |
